PARNAX LAB LTD. - 506128 - Compliance-Compliance As Per Regulation 40 (9) Of Listing Obligations And Disclosure Requirement Regulations 2015.
Dear Sir, Please find enclosed herewith the Compliance Certificate pursuant Regulation 40(9) of Listing Obligations and Disclosure Requirement Regulation 2015 for the half year ended 31st March, 2021. Kindly take the same on your record and acknowledge the receipt of the same. Thanking You, PARNAX LAB LTD. - 506128 - Compliance Certificate For The Period Ended March 31, 2021
Dear Sir, Enclosed please find the Certificate as per Regulation 7(3) of the Listing Obligations for the year ended 31st March , 2021. Kindly take the same on your record and acknowledge receipt of the same. PARNAX LAB LTD. - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir, Pursuant to the provisions of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, Please find enclosed herewith Compliance Certificate received from the Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of our Company for the quarter ended 31st March, 2021. You are requested to take the same on record. PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Namrata KambliDesignation :- Company Secretary and Compliance Officer PARNAX LAB LTD. - 506128 - Closure of Trading Window
Dear Sir/Madam, Pursuant to BSE Circulars dated 2nd April, 2019 vide Ref No: LIST/COMP/01/2019-20 please note that the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons with effect from 01st April, 2021 for the purpose of consideration of Audited Financial result for the quarter and year ended 31st March, 2021. The Trading Window shall open 48 hours after the Audited Financial Result for the quarter and year ended 31st March, 2021 become generally available to the Public. The above is for your information and record. Kindly take the same on your record and oblige. Thanking You, PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Demise
Dear Sir, In Compliance with the Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 , We regret to inform you that Company was intimated today about the sudden and sad demise of Mr. Manharbhai Navalchand Jhavari, Non-Executive Independent Director of the Company, on 27th February, 2021. Mr. Manharbhai Navalchand Jhavari's sudden and unexpected passing away will be an irreparable loss to the Company and all the directors and employees of the Company convey deep sorrow and condolences to his family. Kindly take the above information on record. PARNAX LAB LTD. - 506128 - Results-Financial Results For Quarter And Nine Months Ended 31.12.2020
Dear Sir, Kindly find enclosed herewith the following: 1. A Copy of Standalone & Consolidated Un-Audited Financial results with Limited Review Report of the Company for the quarter and nine months ended 31st December, 2020; Kindly take on record and acknowledge receipt of the same. PARNAX LAB LTD. - 506128 - Outcome Of Board Meeting
Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Saturday, 13th February, 2021 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and nine months ended 31st December, 2020. 2. Considered and took note of Limited Review Report for the quarter and nine months ended 31st December, 2020. The Meeting was commenced at 4.00 p.m. and concluded at 5.00 p.m. Kindly take the same on your record PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St December, 2020.
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter ended 31st December, 2020 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director PARNAX LAB LTD. - 506128 - Shareholding for the Period Ended December 31, 2020
Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here